According to Precedence Research, the global drug of abuse testing market size was estimated at US$ 6.14 billion in 2020 and is expected to hit US$ 10.7 billion by 2030, poised to grow at a noteworthy compound annual growth rate (CAGR) of 6.4% from 2021 to 2030.
The drug of abuse testing market is primarily driven by the factors such as strict laws that mandates the drug abuse testing, growing government initiatives regarding drug abuse, increased consumption of alcohol and other drugs, and increasing mortality due to drugs. Moreover, an increase in the number of clinics and research labs have been witnessed in the past few years that provides drug of abuse testing services. The development of cost effective testing kits and technological advancements in this field has promoted the growth of the market across the globe.
The production and consumption of drugs is growing across the world. According to the United Nations Office on Drugs and Crime, around 246 million people used illicit drug and the population aged between 15 and 64 years, in 2013. A rise of 3 million people was recorded as compared to the previous year. Further, in 2013, around 27 million people were suffering from drug use disorder. Around 24% to 36% of the heroin consuming population passes through correctional system annually in US. Moreover, studies have found that there is a growing prevalence of HIV amongst the people who continues to inject drugs
By drug type, the cannabis segment hit highest revenue share of over 27% in 2021.
In 2021, North America region captured revenue share of over 39.6%.
By product, analyzers segment is expected to grow at a 5.7% CAGR from 2022 to 2030.
Drug Type Insights
By drug type, the marijuana/cannabis segment led the global drug of abuse testing market with remarkable revenue share in 2021. As per the data revealed by the Substance abuse & Mental Health Service Administration, in 2018, around 43.5 million people used marijuana.
On the other hand, the opioids segment is gaining traction due to its growing consumption among the population. According to the National Center for Drug Abuse Statistics, around 2 million US people had opioids use disorder in 2018.
Sample Type Insights
By sample type, the urine segment led the global drug of abuse testing market with remarkable revenue share in 2021. Urine analysis is the most common type of sample testing to detect drug of abuse. Moreover, it is widely used by the work places and criminal justice systems. Further, the growing number of medical centers and clinical labs is fostering the segment growth. The urine analysis is cheap that further boos the growth of this segment across the globe.
End User Insights
By end user, the workplaces segment led the global drug of abuse testing market with remarkable revenue share in 2021.
Source of information NCA/PDA
EN 
ES